Use of buckysome or carbon nanotube for drug delivery
US7070810B2 · kind B2 · utility
41Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 14, 2003 |
| Grant date | Jul 4, 2006 |
| Priority date | — |
| Expiry date | Apr 24, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/1393
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for administering a therapeutic agent to a mammal are disclosed. The compositions comprise either (i) vesicles comprising an amphiphilic substituted fullerene, wherein the therapeutic agent is present in the vesicle interior or between layers of the vesicle wall, (ii) a substituted fullerene, comprising a fullerene core and a functional moiety, wherein the therapeutic agent is associated with the substituted fullerene, or (iii) carbon nanotubes, wherein the therapeutic agent is covalently bonded to the carbon nanotubes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.